Healthcare (Mar 2023)

Prevalence of Symptomatic Knee Osteoarthritis in Saudi Arabia and Associated Modifiable and Non-Modifiable Risk Factors: A Population-Based Cross-Sectional Study

  • Omar W. Althomali,
  • Junaid Amin,
  • Tolgahan Acar,
  • Syed Shahanawaz,
  • Alanazi Talal Abdulrahman,
  • Dalia Kamal Alnagar,
  • Meshari Almeshari,
  • Yasser Alzamil,
  • Kamal Althomali,
  • Noorah Alshoweir,
  • Othman Althomali,
  • Monira I. Aldhahi,
  • Bodor H. Bin Sheeha

DOI
https://doi.org/10.3390/healthcare11050728
Journal volume & issue
Vol. 11, no. 5
p. 728

Abstract

Read online

Objective: This study aimed to determine the prevalence of knee osteoarthritis (OA) in Saudi Arabia and the association between knee OA and modifiable and non-modifiable risk factors. Methods: A self-reported, population-based, cross-sectional survey between January 2021 and October 2021 was conducted. A large, population-representative sample (n = 2254) of adult subjects aged 18 years and over from all regions of Saudi Arabia was collected electronically using convenience sampling. The American College of Rheumatology (ACR) clinical criteria were used to diagnose OA of the knee. The knee injury and osteoarthritis outcome score (KOOS) was used to investigate the severity of knee OA. This study focused on modifiable risk factors (body mass index, education, employment status, marital status, smoking status, type of work, previous history of knee injury, and physical activity level) and non-modifiable risk factors (age, gender, family history of OA, and presence of flatfoot). Results: The overall prevalence of knee OA was 18.9% (n = 425), and women suffered more compared to their male counterparts (20.3% vs. 13.1%, p = 0.001). The logistic regression analysis model showed age (OR: 1.06 [95% CI: 1.05–1.07]; p p p p < 0.01) to be associated with knee OA. Conclusions: A high prevalence of knee OA underlines the need for health promotion and prevention programmes that focus on modifiable risk factors to decrease the burden of the problem and the cost of treatment in Saudi Arabia.

Keywords